Cyclosporine: Nephrotoxic effects and guidelines for safe use in patients with rheumatoid arthritis

Seminars in Arthritis and Rheumatism

Volumn 21, Issue 6 SUPPL. 3, 1992, Pages 43-48

  Cohen, David J ^a   Appel, Gerald B ^a  

^a NONE

Author keywords

Cyclosporine; nephrotoxicity; rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOSPORIN; GOLD DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; LIPOPROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENACETIN;

AMYLOIDOSIS; AUTOIMMUNITY; DRUG ABSORPTION; DRUG SAFETY; DRUG THERAPY; ERYTHROCYTE; GINGIVA HYPERPLASIA; GLOMERULONEPHRITIS; GOUT; HUMAN; HYPERKALEMIA; HYPERMAGNESEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPERURICEMIA; HYPOMAGNESEMIA; KIDNEY TUBULE DISORDER; LIVER METABOLISM; LIVER TOXICITY; NEOPLASM; NEPHROTOXICITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; VASCULITIS;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CYCLOSPORINE; HUMAN; KIDNEY; KIDNEY DISEASES;

EID: 0026751224     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(92)90013-4     Document Type: Article

References (34)

1. Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis
2. Renal disorders in rheumatoid arthritis
3. Effect of the application form of cyclosporine on blood levels: Comparison of oral solution and capsules
4. Cyclosporine
5. Calcium channel blockers and cyclosporine metabolism
6. Cyclosporine-induced hyperuricemia and gout
7. Gout in the heart transplant recipient
8. The pathophysiology of Sandimmune (cyclosporine) in man and animals
9. Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy—Five-year follow-up
10. Cyclosporine-associated chronic nephropathy
11. Cyclosporine nephrotoxicity
12. Evolution of renal function in cardiac and renal allograft recipients receiving long term cyclosporine
13. Long-term effects of cyclosporine on renal function in organ transplant recipients
14. Renal vascular and thrombotic effects of cyclosporine
15. Renal side-effects of cyclosporine
16. Cellular and molecular mechanisms of cyclosporine nephrotoxicity
17. Role of endothelin in cyclosporine-induced renal vasoconstriction
18. Cyclosporine-induced acute renal dysfunction in the rat
19. Cyclosporine A in severe, treatment-refractory rheumatoid arthritis
20. Side effects of cyclosporin A treatment in patients with rheumatoid arthritis
21. Cyclosporine: A treatment of refractory rheumatoid arthritis
22. Cyclosporin A in rheumatoid arthritis: Preliminary clinical results of an open trial
23. Cyclosporin treatment of rheumatoid arthritis: A placebo controlled double blind multi-center study
24. An open controlled randomized comparison of cyclosporine and azathioprine in the treatment of rheumatoid arthritis
25. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
26. Use of cyclosporin A (Sandimmune) in idiopathic nephrotic syndrome (clinical results worldwide)
27. Cyclosporine therapy in steroid refractory nephrotics
28. Cyclosporine A induced remission of relapsing nephrotic syndrome in children
29. Adult steroid-resistant nephrotic FSGS is not an indication for CsA treatment
30. Glomerular filtration rate (GFR) and renal histology in cyclosporine (CSA)treated psoriasis patients
31. Evaluation of nephrotoxicity by sequential biopsies in 38 children with idiopathic nephrosis treated with cyclosporine A
32. The effects of ciclosporin in severe systemic lupus erythematosus
33. Ciclosporin in the treatment of lupus nephritis
34. Morphologic evolution of membranous lupus glomerulonephritis on combined treatment of cyclosporine and steroids